Pfizer

News

Digital innovation drives vaccine development

COVID vaccines not linked to excess deaths, says CDC

There is no evidence that vaccination with either the Pfizer/BioNTech or Moderna's mRNA-based COVID-19 vaccines led to the death of patients, says a study by researchers at the Centres for

News

After GSK stumble, Pfizer moves forward with RSV vaccine

Pfizer has been awarded breakthrough status from the FDA for its respiratory syncytial virus (RSV) vaccine in pregnant women, putting the company in pole position to bring a shot to market

News

Pfizer's seeks silver lining in failed C. diff vaccine trial

Pfizer's vaccine for Clostridium difficile (C.

R&D

Examining COVID’s impact on clinical research participant di...

The clinical research industry has long struggled with participant diversity.

News

COVID jabs now offered to all children aged 5 to 11 across U...

England and Northern Ireland have followed Wales and Scotland in offering healthy children aged between five and 11 a low-dose COVID-19 vaccine, making vaccination an option for a younger a

News

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

Pfizer reckons it will make a whopping $22 billion in sales of its oral COVID-19 antiviral Paxlovid in 2022, with another $32 billion from its BioNTech-partnered coronavirus vaccine Comirna

COVID vaccines not linked to excess deaths, says CDC

After GSK stumble, Pfizer moves forward with RSV vaccine

Pfizer's seeks silver lining in failed C. diff vaccine trial

Examining COVID’s impact on clinical research participant di...

COVID jabs now offered to all children aged 5 to 11 across U...

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Pfizer

Editor's Picks